Impact of Delaying Disease Recurrence on Economic Burden in Patients with HER2+ Early-Stage Breast Cancer (eBC)

Nicole Princic,1 Eleanor Faherty,2 Meghan Moynihan,1 Caroline Henriques,2 Sandhya Mehta1 1Data Research & Analytics, Real World Data, MarketScan by Merative, Ann Arbor, MI, USA; 2HEOR & RWE, US Medical Affairs, Daiichi Sankyo, Inc., Basking Ridge, NJ, USACorrespondence: Sandhya Mehta, Daiich...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Princic N, Faherty E, Moynihan M, Henriques C, Mehta S
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2026-02-01
Serie:	ClinicoEconomics and Outcomes Research
Soggetti:	Breast cancer Neoadjuvant therapy Adjuvant drug therapy Recurrence Health Care Costs
Accesso online:	https://www.dovepress.com/impact-of-delaying-disease-recurrence-on-economic-burden-in-patients-w-peer-reviewed-fulltext-article-CEOR
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!